The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Cuomo Puts Fidelity and Goldman Under the Microscope Not Rated 0.0 Email Routing List Email & Route  Print Print
Wednesday, August 27, 2008

Cuomo Puts Fidelity and Goldman Under the Microscope

by: Armie Margaret Lee

The Wednesday edition of the Wall Street Journal's Fund Track column provides an update of New York Attorney General Andrew Cuomo's auction-rate securities probe. Cuomo's office is looking into whether Fidelity's ties with Goldman Sachs may have given the Boston Behemoth an incentive to sell the securities to individual investors, reports Jennifer Levitz. Citing an unidentified source, Levitz writes that the attorney general began pursuing that angle after finding out that most of the auction-rate securities sold by Fidelity were underwritten by Goldman.

The attorney general's office is said to be investigating whether Fidelity may have sold the securities because it was getting other services from Goldman.

Fidelity spokeswoman Anne Crowley told Levitz that there's no incentive for Fidelity to promote auction-rate securities. Crowley also said 600 Fidelity accounts held such securities. Goldman Sachs declined to comment on the investigation.

Earlier this month, word came that Cuomo has included Fidelity in his widening ARS investigation (see The MFWire, August 18, 2008.) 

Stay ahead of the news ... Sign up for our email alerts now

 Do You Recommend This Story?

Return to Top
 News Archives
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Add to My Yahoo!
follow us in feedly

©All rights reserved to InvestmentWires, Inc. 1997-2022
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use